TuisCRNX • NASDAQ
add
Crinetics Pharmaceuticals Inc
Vorige sluiting
$29,99
Dagwisseling
$29,59 - $30,85
Jaarwisseling
$24,10 - $62,53
Markkapitalisasie
2,81 mjd USD
Gemiddelde volume
685,24 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 361,00 k | -43,59% |
Bedryfskoste | 35,53 m | 70,57% |
Netto inkomste | -96,77 m | -44,59% |
Netto winsgrens | -26,81 k | -156,34% |
Wins per aandeel | -1,04 | -11,83% |
EBITDA | -110,48 m | -51,23% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 1,27 mjd | 41,42% |
Totale bates | 1,36 mjd | 39,17% |
Totale aanspreeklikheid | 107,33 m | 3,98% |
Totale ekwiteit | 1,25 mjd | — |
Uitstaande aandele | 93,68 m | — |
Prys om te bespreek | 2,24 | — |
Opbrengs op bates | -19,92% | — |
Opbrengs op kapitaal | -20,77% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -96,77 m | -44,59% |
Kontant van bedrywe | -88,45 m | -67,35% |
Kontant van beleggings | -85,96 m | -27 919,09% |
Kontant van finansiering | 4,44 m | -98,87% |
Netto kontantverandering | -169,98 m | -149,84% |
Beskikbare kontantvloei | -47,18 m | -69,57% |
Meer oor
Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018. Wikipedia
Gestig
18 Nov. 2008
Webwerf
Werknemers
437
